Document Hospitals Medication Dispensing 
Drug Topics
AUGUST 8, 2025
Shortages of physicians and nurses in primary care will lead to more opportunities for pharmacists to deliver health care services beyond medication dispensing. 4 Artificial intelligence (AI) systems are quickly evolving to assist with diagnosing health problems, tailoring drug therapy, and completing clinical documentation.
Pharmacy Times
JUNE 17, 2025
This research shows the impactful interventions implemented within a medically integrated pharmacy (MIP) model, specifically focusing on how oncology-trained nurses can leverage comprehensive chart reviews and reassessments to identify discrepancies before medication dispensation, ultimately leading to substantial cost avoidance and waste reduction.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
JANUARY 10, 2023
Our anesthesia department recently formed a new diversion-prevention team within the hospital. The Chief of Anesthesia is now aware of flaws in documentation and has an awareness of open transactions through enhanced data visibility.
Omnicell
JANUARY 10, 2023
Patrick Guffey, MD, Chief Medical Information Officer at Children's Hospital Colorado and Anesthesiologist at Children's Hospital Colorado, on the latest edition of the Future of Pharmacy Podcast to discuss achieving the delicate balance of medication management in the operating room.
indispensable health
AUGUST 18, 2023
Technology offers a lifeline by automating documentation, report generation, and data entry: A. Voice Recognition Technology: Dictating notes through voice recognition software expedites documentation, freeing nurses from typing and ensuring accurate records.
Omnicell
JANUARY 10, 2023
When you consider that the OR accounts for 40% of hospital expenses and 70% of revenue , why wouldn’t you want optimal medication management in such a critical area? Omnicell has continued to refine medication workflow with the XT Anesthesia Workstation™ , and new functionality helps both parties accomplish this goal.
The FDA Law Blog
OCTOBER 17, 2023
Background The Breakthrough Devices Program, established under section 515B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is a voluntary program for certain medical devices and device-led combination products. By Philip Won & Lisa M. Wysa, see here ) and addiction (e.g., reSET-O, see here , here ).
Expert insights. Personalized for you.
Let's personalize your content